Lemaitre Vascular (LMAT) Misses Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q1 EPS of $0.13, $0.02 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $23.3 million versus the consensus estimate of $23.59 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lemaitre Vascular (LMAT) Misses Q3 EPS by 4c ; Offers Guidance
- HCI Group (HCI) Tops Q3 EPS by 245c
- eHealth (EHTH) Misses Q3 EPS by 45c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
